The short-term results of modified limberg flap in treatment of pilonidal sinus disease

Elsayed, Khalid Goda; Heggy, Ibrahim; Sarhan, Abd-Elrahman

doi:10.21608/zumj.2021.52827.2040

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar complications were also noted by Baz et al 14 Patient feedback indicated that the majority (62%) experienced excellent results, followed by 21% reporting good outcomes and 17% reporting fair outcomes. Comparable levels of patient satisfaction were reported in a study by Elsayed et al 15 Consistent with our findings, Bali et al concluded that the Limberg flap procedure is a safe and effective option for treating recurrent pilonidal sinus disease, citing its low complication rate, short hospital stays, early return to work, low pain scores, high patient satisfaction, and shorter healing duration. 13 Consequently, we also advocate for the use of the Limberg flap procedure in treating recurrent pilonidal sinus disease.…”

Section: Discussionsupporting

confidence: 92%

Outcomes of Limberg flap repair in recurrent pilonidal sinus disease: a study in a district hospital of Bangladesh

Rajib,

Afroz,

Islam

et al. 2024

Int Surg J

View full text Add to dashboard Cite

Background: Pilonidal sinus disease (PSD) is a chronic condition affecting the sacrococcygeal region, often seen in young adults. Numerous surgical techniques have been documented in medical literature for its treatment. This study aimed to evaluate the outcomes of the Limberg flap repair (LFR) in recurrent pilonidal sinus disease. Methods: This prospective observational study was conducted in the General Hospital, Nilphamari, Bangladesh from January 2021 to December 2022. The study included 47 cases of recurrent PSD scheduled for LFR, selected through purposive sampling. Data analysis was conducted using Microsoft office tools. Results: In the analysis of outcomes, the study found the following mean±SD values: operation duration of 53.4±7.2 minutes, first mobilization at 1.1±0.2 days, work incapacity for 7.3±1.5 days, pain visual analog score (VAS) score of 1.7±0.3, complete healing in 21.7±7.9 days, and painless toilet seating achieved in 1.2±0.6 days for all participants. Postoperative complications included seroma (8.5%) and hematoma (6.4%) in more than 5% of participants. Most patients achieved excellent results (62%), followed by 21% with good and 17% with fair outcomes. Conclusions: LFR stands out as an effective and safe treatment option for recurrent PSD. It offers advantages such as reduced complication rates, shorter hospital stays, quicker return to work, minimal pain, and high patient satisfaction.

show abstract

Section: Discussionsupporting

confidence: 92%